Endocrinología y Nutrición, Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Spain
Obstetricia y Ginecología, Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Spain.
BMJ Open Diabetes Res Care. 2022 Dec;10(6). doi: 10.1136/bmjdrc-2022-002915.
To compare the conventional treatment of gestational diabetes mellitus (GDM) with flexible treatment according to the measurement of fetal abdominal circumference (AC) in daily clinical practice.
Two hundred and sixty pregnant women diagnosed with GDM before week 34 were randomly placed in two groups: a control group, treated according to maternal capillary glycemia, and an experimental group, treated according to ultrasound parameters of fetal growth. The glycemic targets in the control group were blood glucose levels when fasting and 1 hour postprandial (<95/140 mg/dL). In the experimental group, glycemic targets depended on the percentile (p) of fetal AC: if AC p <75th, then blood glucose targets when fasting and at 1 hour postprandial were <120/180 mg/dL; and if AC p ≥75th, then the glycemic targets were <80/120 mg/dL. The follow-up of both groups was scheduled according to the GDM protocol of our diabetes and gestation unit.
The study was completed by 246 pregnant women, 125 in the control group and 121 in the experimental group. In the experimental group, insulin treatment and neonatal hypoglycemia were significantly lower (p=0.018 and p 0.035, respectively). No differences were observed in large and small infants according to gestational age. However, macrosomic infants were less frequent in the experimental group, although this difference did not reach statistical significance. In terms of gestation complications, the type of delivery and its complications and the rest of the neonatal complications analyzed, no significant differences were observed.
The treatment of flexible GDM according to the measurement of fetal AC is safe for the mother and the fetus and almost halves the number of pregnant women who require insulin treatment, without increasing the number of ultrasound checks or medical visits.
比较常规治疗妊娠期糖尿病(GDM)与根据胎儿腹围(AC)测量值进行的灵活治疗在日常临床实践中的效果。
将 260 名在 34 周前被诊断为 GDM 的孕妇随机分为两组:对照组按产妇毛细血管血糖治疗,实验组按胎儿生长的超声参数治疗。对照组的血糖目标是空腹和餐后 1 小时血糖水平(<95/140mg/dL)。在实验组中,血糖目标取决于胎儿 AC 的百分位数(p):如果 AC p <75th,则空腹和餐后 1 小时血糖目标为<120/180mg/dL;如果 AC p ≥75th,则血糖目标为<80/120mg/dL。两组的随访均按照我们糖尿病和妊娠单位的 GDM 方案进行。
本研究完成了 246 名孕妇的随访,其中对照组 125 名,实验组 121 名。在实验组中,胰岛素治疗和新生儿低血糖的发生率显著降低(p=0.018 和 p<0.035)。根据胎龄,两组的巨大儿和小样儿发生率没有差异。然而,实验组中巨大儿的发生率较低,但差异无统计学意义。在妊娠并发症方面,分娩方式及其并发症和其他新生儿并发症的分析中,未观察到显著差异。
根据胎儿 AC 测量值灵活治疗 GDM 对母婴均安全,几乎使需要胰岛素治疗的孕妇数量减半,同时不会增加超声检查或就诊次数。